The FDA last week banned the import of antibiotics and other drugs from three more companies in China and India. Drugs produced by Gooey Bio-Technology Co. Ltd., of Ningbo, China, Cheryl Laboratories Pvt Ltd., of Mumbai, and Phalanx Labs Pvt Ltd., of Parawada, India, were placed on the agency's Red List, which means products from the companies cannot be imported into the U.S. because the firms refused an FDA inspection.